Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $34.15 billion. The enterprise value is $35.68 billion.
Market Cap | 34.15B |
Enterprise Value | 35.68B |
Important Dates
The next confirmed earnings date is Tuesday, July 30, 2024, before market open.
Earnings Date | Jul 30, 2024 |
Ex-Dividend Date | May 30, 2024 |
Share Statistics
Xylem has 242.45 million shares outstanding. The number of shares has increased by 34.03% in one year.
Shares Outstanding | 242.45M |
Shares Change (YoY) | +34.03% |
Shares Change (QoQ) | +0.21% |
Owned by Insiders (%) | 0.65% |
Owned by Institutions (%) | 93.73% |
Float | 240.62M |
Valuation Ratios
The trailing PE ratio is 49.07 and the forward PE ratio is 32.22. Xylem's PEG ratio is 2.28.
PE Ratio | 49.07 |
Forward PE | 32.22 |
PS Ratio | 4.32 |
Forward PS | 3.92 |
PB Ratio | 3.37 |
P/FCF Ratio | 52.77 |
PEG Ratio | 2.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.11, with an EV/FCF ratio of 54.80.
EV / Earnings | 53.81 |
EV / Sales | 4.49 |
EV / EBITDA | 28.11 |
EV / EBIT | 47.00 |
EV / FCF | 54.80 |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.22.
Current Ratio | 1.67 |
Quick Ratio | 1.11 |
Debt / Equity | 0.22 |
Debt / EBITDA | 1.79 |
Debt / FCF | 3.49 |
Interest Coverage | 14.06 |
Financial Efficiency
Return on equity (ROE) is 6.60% and return on invested capital (ROIC) is 5.51%.
Return on Equity (ROE) | 6.60% |
Return on Assets (ROA) | 4.10% |
Return on Capital (ROIC) | 5.51% |
Revenue Per Employee | $345,609 |
Profits Per Employee | $28,826 |
Employee Count | 23,000 |
Asset Turnover | 0.50 |
Inventory Turnover | 5.30 |
Taxes
In the past 12 months, Xylem has paid $42.00 million in taxes.
Income Tax | 42.00M |
Effective Tax Rate | 5.96% |
Stock Price Statistics
The stock price has increased by +23.73% in the last 52 weeks. The beta is 1.04, so Xylem's price volatility has been similar to the market average.
Beta (5Y) | 1.04 |
52-Week Price Change | +23.73% |
50-Day Moving Average | 138.81 |
200-Day Moving Average | 121.41 |
Relative Strength Index (RSI) | 57.00 |
Average Volume (20 Days) | 1,072,725 |
Short Selling Information
The latest short interest is 3.40 million, so 1.40% of the outstanding shares have been sold short.
Short Interest | 3.40M |
Short Previous Month | 3.92M |
Short % of Shares Out | 1.40% |
Short % of Float | 1.41% |
Short Ratio (days to cover) | 3.05 |
Income Statement
In the last 12 months, Xylem had revenue of $7.95 billion and earned $663.00 million in profits. Earnings per share was $2.87.
Revenue | 7.95B |
Gross Profit | 2.92B |
Operating Income | 730.00M |
Pretax Income | 705.00M |
Net Income | 663.00M |
EBITDA | 1.27B |
EBIT | 759.00M |
Earnings Per Share (EPS) | $2.87 |
Balance Sheet
The company has $947.00 million in cash and $2.27 billion in debt, giving a net cash position of -$1.32 billion or -$5.46 per share.
Cash & Cash Equivalents | 947.00M |
Total Debt | 2.27B |
Net Cash | -1.32B |
Net Cash Per Share | -$5.46 |
Equity (Book Value) | 10.20B |
Book Value Per Share | 42.05 |
Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was $945.00 million and capital expenditures -$294.00 million, giving a free cash flow of $651.00 million.
Operating Cash Flow | 945.00M |
Capital Expenditures | -294.00M |
Free Cash Flow | 651.00M |
FCF Per Share | $2.69 |
Margins
Gross margin is 36.77%, with operating and profit margins of 9.18% and 8.34%.
Gross Margin | 36.77% |
Operating Margin | 9.18% |
Pretax Margin | 8.87% |
Profit Margin | 8.34% |
EBITDA Margin | 15.96% |
EBIT Margin | 9.55% |
FCF Margin | 8.19% |
Dividends & Yields
This stock pays an annual dividend of $1.44, which amounts to a dividend yield of 1.02%.
Dividend Per Share | $1.44 |
Dividend Yield | 1.02% |
Dividend Growth (YoY) | 9.52% |
Years of Dividend Growth | 12 |
Payout Ratio | 50.17% |
Buyback Yield | -34.03% |
Shareholder Yield | -33.02% |
Earnings Yield | 1.93% |
FCF Yield | 1.90% |
Analyst Forecast
The average price target for Xylem is $144.58, which is 2.66% higher than the current price. The consensus rating is "Buy".
Price Target | $144.58 |
Price Target Difference | 2.66% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Revenue Growth Forecast (5Y) | 8.13% |
EPS Growth Forecast (5Y) | 18.08% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.61 and a Piotroski F-Score of 4.
Altman Z-Score | 4.61 |
Piotroski F-Score | 4 |